Burlingame, CA, United States of America

Attralus, Inc.

Calculating rank

USPTO Granted Patents = 5

Trademarks = 2

Forward Citations = 5

Loading Chart...

5 inventors (with patents filed for the assignee):

Jonathan Wall (5 out of 70 patents)

James S Foster (4 out of 8 patents)

Spencer Guthrie (4 out of 4 patents)

4. Jaume Pons (2 out of 59 patents)

5. Michael L Klein (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12264195 - Modified immunoglobulins for targeting amyloid deposits (2025-04-01),

2. 12161692 - SAP FC fusion proteins and methods of use (2024-12-10),

3. 12157765 - Modified immunoglobulins for targeting amyloid deposits (2024-12-03),

4. 12139529 - Antibody-peptide fusion proteins for treating amyloid disorders (2024-11-12),

5. 12030934 - Modified immunoglobulins for targeting amyloid deposits (2024-07-09),

Company Overview

Attralus, Inc. is a biotechnology company focused on developing innovative therapies for patients with rare diseases. The company leverages its proprietary technology platform to discover and develop novel treatments that address unmet medical needs. Attralus is committed to advancing science and improving patient outcomes through rigorous research and collaboration with healthcare professionals. With a strong emphasis on clinical development, Attralus aims to bring transformative therapies to market, enhancing the quality of life for individuals affected by challenging health conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#49 in Burlingame, CA

#12,079 in California

#51,669 in US

Burlingame, CA, United States of America

Attralus, Inc.

Forward Citations = 5

5 inventors:

Jonathan Wall (5 out of 70 patents)

James S Foster (4 out of 8 patents)

Spencer Guthrie (4 out of 4 patents)

4. Jaume Pons (2 out of 59 patents)

5. Michael L Klein (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Attralus, Inc.. Retrieved from https://idiyas.com/company/attralus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]